The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year strategic alliance to accelerate the clinical evaluation and development of Myriad's molecular ...

I’m an oncologist. The surgeon general’s warning about alcohol was long overdue.

Acquisition provides access to critical resources encompassing a biobank of more than 150,000 tumor specimens, 200,000 pathology slides and ...

A new study evaluating the quadratic phenotypic optimization platform shows it can accurately predict personalized drug ...

To access the live webcast of the presentation, please visit the “Events & Presentations” page of Revolution Medicines’ website at Additionally, a replay of the webcast will be available on the ...

Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), announced results from a Phase 1b clinical signal detection study evaluating the safety and efficacy of the novel ...

Valley Medical Center next month will open the first phase of a new cancer facility that will increase its capacity to treat ...